KORU MEDICAL SYSTEMS INC (KRMD) Stock Analyst Earnings Estimates
NASDAQ:KRMD - Nasdaq - US7599101026 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 23.49M -2.85% | 27.9M 18.77% | 28.518M 2.21% | 34.371M 20.53% | 39.161M 13.94% | 45.531M 16.27% | |
| EBITDA YoY % growth | -6.57M -505.56% | -10.19M -55.10% | -9.4M 7.76% | -2.819M 70.01% | -459K 83.72% | 4.162M 1,006.75% | |
| EBIT YoY % growth | -7.03M -685.83% | -10.78M -53.34% | -10.27M 4.73% | -6.658M 35.17% | -4.788M 28.10% | -2.125M 55.61% | |
| Operating Margin | -29.93% | -38.64% | -36.01% | -19.37% | -12.23% | -4.67% | |
| EPS YoY % growth | -0.10 -233.33% | -0.20 -100.00% | -0.16 20.00% | -0.13 17.25% | -0.09 32.97% | -0.03 68.59% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.03 -4.04% | -0.03 -53.00% | -0.02 -22.40% | -0.02 25.20% | -0.01 52.94% | -0.02 43.33% | -0.01 70.83% | -0.01 69.68% | 0.00 113.89% |
| Revenue Q2Q % growth | 9.077M 26.32% | 8.976M 9.49% | 9.538M 13.14% | 9.864M 20.60% | 10.72M 18.10% | 10.589M 17.97% | 11.2M 17.43% | 11.491M 16.49% | 12.216M 13.96% |
| EBITDA Q2Q % growth | -864.45K 34.87% | -383.265K 61.74% | -158.865K 87.63% | 46.41K 103.96% | 287.895K 133.30% | 885.36K 331.00% | 1.242M 881.80% | 751.74K 1,519.78% | 1.158M 302.23% |
| EBIT Q2Q % growth | -1.699M 22.71% | -1.549M 22.13% | -1.255M 45.82% | -1.193M 43.48% | -765.408K 54.94% | -923.61K 40.36% | -532.95K 57.55% | -612K 48.72% | -107.61K 85.94% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.03 | -0.04 | 0.01 | 22.60% |
| Q2 2024 Q2Q % growth | -0.02 60.00% | -0.04 | 0.02 | 53.31% |
| Q1 2024 Q2Q % growth | -0.02 60.00% | -0.04 | 0.02 | 48.40% |
| Q4 2023 Q2Q % growth | -0.03 25.00% | -0.04 | 0.01 | 26.47% |
| Q3 2023 Q2Q % growth | -0.03 | -0.05 | 0.02 | 41.18% |
| Q2 2023 Q2Q % growth | -0.05 28.57% | -0.06 | 0.01 | 13.50% |
| Q1 2023 Q2Q % growth | -0.05 16.67% | -0.05 | 0.00 | 1.96% |
| Q4 2022 Q2Q % growth | -0.04 -100.00% | -0.06 | 0.02 | 30.80% |
| Q3 2022 Q2Q % growth | -0.03 -50.00% | -0.05 | 0.02 | 44.85% |
| Q2 2022 Q2Q % growth | -0.07 -133.33% | -0.07 | 0.00 | 1.96% |
| Q1 2022 Q2Q % growth | -0.06 -100.00% | -0.06 | 0.00 | -3.80% |
| Q4 2021 Q2Q % growth | -0.02 | -0.03 | 0.01 | 41.17% |
| Q3 2021 Q2Q % growth | -0.02 -300.00% | -0.02 | 0.00 | 15.95% |
| Q2 2021 Q2Q % growth | -0.03 | -0.02 | -0.01 | -47.06% |
| Q1 2021 Q2Q % growth | -0.03 -400.00% | -0.01 | -0.02 | -340.96% |
| Q4 2020 Q2Q % growth | -0.02 | -0.01 | -0.01 | -193.97% |
| Q3 2020 Q2Q % growth | 0.01 -50.00% | 0.02 | -0.01 | -52.75% |
| Q2 2020 Q2Q % growth | -0.03 | 0.02 | -0.05 | -247.06% |
| Q1 2020 Q2Q % growth | 0.01 | 0.01 | 0.00 | -1.96% |
| Q4 2019 Q2Q % growth | 0.00 | 0.01 | -0.01 | -100.00% |
| Q2 2019 Q2Q % growth | 0.00 | 0.01 | -0.01 | -100.00% |
| Q1 2019 Q2Q % growth | 0.00 | 0.01 | -0.01 | -100.00% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 8.179M 16.84% | 7.834M | 345K | 4.40% |
| Q2 2024 Q2Q % growth | 8.43M 21.47% | 7.721M | 709.09K | 9.18% |
| Q1 2024 Q2Q % growth | 8.198M 10.93% | 7.616M | 581.8K | 7.64% |
| Q4 2023 Q2Q % growth | 7.186M -2.10% | 7.083M | 103K | 1.45% |
| Q3 2023 Q2Q % growth | 7M -9.79% | 8.088M | -1.088M | -13.45% |
| Q2 2023 Q2Q % growth | 6.94M 5.95% | 7.368M | -428K | -5.81% |
| Q1 2023 Q2Q % growth | 7.39M 18.43% | 7.588M | -198K | -2.61% |
| Q4 2022 Q2Q % growth | 7.34M 13.10% | 7.528M | -188K | -2.50% |
| Q3 2022 Q2Q % growth | 7.76M 28.48% | 6.91M | 850K | 12.30% |
| Q2 2022 Q2Q % growth | 6.55M 18.44% | 6.412M | 138K | 2.15% |
| Q1 2022 Q2Q % growth | 6.24M 14.92% | 6.19M | 50K | 0.81% |
| Q4 2021 Q2Q % growth | 6.49M 59.85% | 6.185M | 305K | 4.93% |
| Q3 2021 Q2Q % growth | 6.04M -0.66% | 5.524M | 516K | 9.34% |
| Q2 2021 Q2Q % growth | 5.53M -28.27% | 5.315M | 215K | 4.05% |
| Q1 2021 Q2Q % growth | 5.43M -14.22% | 5.203M | 227K | 4.36% |
| Q4 2020 Q2Q % growth | 4.06M -34.73% | 4.766M | -706K | -14.81% |
| Q3 2020 Q2Q % growth | 6.08M -8.16% | 7.251M | -1.171M | -16.15% |
| Q2 2020 Q2Q % growth | 7.71M 44.11% | 6.648M | 1.062M | 15.97% |
| Q1 2020 Q2Q % growth | 6.33M 27.36% | 6.324M | 6K | 0.09% |
| Q4 2019 Q2Q % growth | 6.22M | 5.47M | 750K | 13.71% |
| Q3 2019 Q2Q % growth | 6.62M | 5.588M | 1.032M | 18.47% |
| Q2 2019 Q2Q % growth | 5.35M | 5.235M | 115K | 2.20% |
| Q1 2019 Q2Q % growth | 4.97M | 4.937M | 33K | 0.67% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | -5.53% | 7.29% |
| Revenue | 0% | 0% | 0.4% | 4.39% |